(Press-News.org) The American College of Medical Genetics and Genomics (ACMG) has released its highly anticipated 2023 update to the recommended minimum gene list for the reporting of secondary findings (SF): “ACMG SF v3.2 List for Reporting of Secondary Findings in Clinical Exome and Genome Sequencing: A Policy Statement of the American College of Medical Genetics and Genomics (ACMG).” In 2021, the ACMG Board of Directors and Secondary Findings Working Group (SFWG) stated that the College would update the list annually. Today’s update (SF v3.2) is being published in ACMG’s flagship journal, Genetics in Medicine.
Three new cardiovascular genes, CALM1, CALM2 and CALM3, were added to the SF v3.2 list along with a brief description of the factors considered in adding each of these genes. One gene, ATP7A, was also considered carefully for inclusion but ultimately excluded from the SF v3.2 list. This gene could be reviewed again in the future if new data emerges related to either Menkes disease or other phenotypes associated with ATP7A.
“We continue to balance the goals of providing secondary findings to patients while striving for a minimum list of the most actionable, and impactful, secondary findings,” said lead author and co-chair of the ACMG SFWG, David T. Miller, MD, PhD, FACMG.
Christa L. Martin, PhD, FACMG, co-chair of the SFWG added, “We’re excited to continue with our plans to publish updates to the list about one time per year and encourage ACMG members and others to submit nominations as part of this ongoing process.”
Guidance from the original ACMG policy statement on incidental (updated later to the current term, “secondary”) findings in 2013 established that clinical laboratories performing exome or genome sequencing should report a “minimum list” of known pathogenic or likely pathogenic variants in a defined set of genes considered medically actionable, even when unrelated to the primary medical reasons for testing.
The current ACMG Secondary Findings Working Group includes clinical geneticists, molecular and/or cytogenetics clinical laboratory directors, genetic counselors, cardiologists, an expert in hereditary cancer predisposition, and a bioethicist.
Note that the versioning nomenclature of the ACMG SF list was designed to differentiate major versus minor revisions. Major revisions include conceptual changes to the categories or genes/variants in the SF list or the removal or addition of a large number of genes in a single update. These major changes are denoted by updating the version number to the next integer, e.g., v4.0 or v5.0. Minor revisions, such as the 2023 release of SF v3.2, reflect the addition or removal of one or a few genes or variants without any significant policy change.
The ACMG SFWG will continue to review the current list of actionable genes, as well as new nominations throughout the course of the year including nominations submitted through representatives of other professional organizations and individuals via the nomination form on the ACMG website.
About the American College of Medical Genetics and Genomics (ACMG) and ACMG Foundation
Founded in 1991, the American College of Medical Genetics and Genomics (ACMG) is a prominent authority in the field of medical genetics and genomics and the only nationally recognized medical professional organization solely dedicated to improving health through the practice of medical genetics and genomics. The only medical specialty society in the US that represents the full spectrum of medical genetics disciplines in a single organization, the ACMG provides education, resources and a voice for more than 2,600 clinical and laboratory geneticists, genetic counselors and other healthcare professionals. ACMG’s mission is to improve health through the clinical and laboratory practice of medical genetics as well as through advocacy, education and clinical research, and to guide the safe and effective integration of genetics and genomics into all of medicine and healthcare, resulting in improved personal and public health. Genetics in Medicine and the new Genetics in Medicine Open, a gold open access journal, are the official ACMG journals. ACMG’s website, www.acmg.net, offers resources including policy statements, practice guidelines, and educational programs. The ACMG Foundation for Genetic and Genomic Medicine works to advance ACMG educational and public health programs through charitable gifts from corporations, foundations and individuals.
-end-
END
NEW YORK, NY – June 22, 2023 – The Lupus Research Alliance awarded its 2023 Lupus Insight Prize to Carola Vinuesa, MD, PhD, of The Francis Crick Institute, for her seminal discovery that a mutation in a specific human gene causes systemic lupus erythematosus (SLE), uncovering an important target for the development of novel treatment. The Lupus Insight Prize is awarded each year to an outstanding investigator who has made a significant discovery that will advance our understanding of the pathogenesis, diagnosis, or treatment of lupus.
Dr. Vinuesa ...
In the United States, sickle cell disease affects about 100,000 people and about 2 million Americans carry this genetic mutation. The most common and serious problems caused by sickle cell disease are anemia, pain and organ failure – stroke affects about 10 out of 100 children who have this disease. The national median life expectancy for people who have sickle cell disease can reach up to age 50.
This inherited, lifelong blood disorder is characterized by rigid and sickle-shaped red blood cells due to a dramatic change in their morphology. They stick to blood vessels, blocking ...
Washington, D.C. – Investigators in Israel and Italy have developed a model of the blood-brain barrier, studies of which may lead to prevention of meningitis in newborns. The research is published in Microbiology Spectrum, a journal of the American Society for Microbiology.
The investigators further developed a platform called organs-on-a-chip—invented during the 2000s—to construct the model. These devices, which are modeled after microchips, contain tiny channels lined with living human ...
Leishmaniasis is a tropical disease caused by parasites known as Leishmania, which are transmitted to humans and animals through the bites of more than 90 species of sand flies. Considered a neglected tropical disease, leishmaniasis is found in approximately 88 countries primarily located in South and Central America, the Middle East and western Asia. As many as 1 million new cases are diagnosed each year and more than 350 million people are at risk of infection. Some forms of the disease ...
The UK is to launch a clinical trial of a ‘poo transplant’ that researchers believe could treat advanced liver disease and fight antimicrobial resistance.
The trial’s investigators also provide evidence for the first time that a faecal transplant can dramatically improve gut health.
The PROMISE trial is led by King’s College London and funded by a National Institute for Health and Care Research (NIHR) and Medical Research Council (MRC) partnership. It will recruit patients with cirrhosis from across the UK to test whether oral Faecal Microbiota Transplant (FMT) capsules from freeze-dried stool from healthy volunteers reduces the likelihood of getting an ...
Alexandria, VA, USA – A study that introduces a new strategy to promote customized, oral health self-care by using an online platform to connect dental professionals and patients will be presented at the 101st General Session of the IADR, which will be held in conjunction with the 9th Meeting of the Latin American Region and the 12th World Congress on Preventive Dentistry on June 21-24, 2023, in Bogotá, Colombia.
The Interactive Talk presentation, “An Online Platform to Promote Customized Self Oral Healthcare,” will take place on Thursday, ...
Alexandria, VA, USA – A study examining the effect of COVID-19 lockdowns on Bolivian dental school graduates will be presented at the 101st General Session of the IADR, which will be held in conjunction with the 9th Meeting of the Latin American Region and the 12th World Congress on Preventive Dentistry on June 21-24, 2023, in Bogotá, Colombia.
The Interactive Talk presentation, “Covid–19 Pandemic Effects on Graduates’ Self Confidence to Execute Dental Clinical Procedures,” will take place on Thursday, June 22, 2023, at 2 p.m. Colombia Time (UTC-05:00) during the “Attitude ...
Patients with a rare genetic bone marrow disorder which puts them at increased risk of blood cancers could benefit from a discovery that may lead to new treatments to slow or reverse the disease.
In a new study published in Cell Reports, scientists from the University of Birmingham and University of Warwick have found that affected blood stem cells that are produced in bone marrow produce much fewer immune cells used to fight infection. The mutation in the GATA2 gene in these blood stem cells results in impaired ability to repair ongoing damage to their DNA and puts patients at risk of developing blood cancers. The median age for patients developing Acute Myeloid Leukaemia who ...
PULLMAN, Wash. – Taking a cue from the structural complexity of trees and bones, Washington State University engineers have created a way to 3D-print two types of steel in the same circular layer using two welding machines. The resulting bimetallic material proved 33% to 42% stronger than either metal alone, thanks in part to pressure caused between the metals as they cool together.
The new method uses commonplace, relatively inexpensive tools, so manufacturers and repair shops could use it in the ...
Butterflies are being hit hardest by urban growth. Shrinking habitats and food availability are causing their populations to decline. The same applies to many wild bees that fly early in spring. According to a new study by the Martin Luther University Halle-Wittenberg (MLU) and the Chinese Academy of Sciences in "Ecology Letters", pollination has not yet been impacted by this because honeybees, for example, can compensate for the reduction of urban pollinators. The study is the first comprehensive analysis of the subject and includes data from 133 studies. The results underline the importance ...
